AGN: Allergan plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 63,364.03
Enterprise Value ($M) 83,888.73
Book Value ($M) 57,997.70
Book Value / Share 175.85
Price / Book 1.09
NCAV ($M) -22,930.60
NCAV / Share -69.53
Price / NCAV -2.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.05
Return on Equity (ROE) -0.08

Liquidity (mrq)
Quick Ratio 0.84
Current Ratio 1.01

Balance Sheet (mrq) ($M)
Current Assets 7,474.10
Assets 88,426.20
Liabilities 30,404.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -4,445.30
Net Income -5,265.10
Earnings Per Share Diluted -16.02
Earnings Per Share Basic -16.02

Cash Flow Statement (mra) ($M)
Cash From Operations 7,238.70
Cash from Investing -2,858.80
Cash from Financing -2,858.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
06-01 13D/A Cf Partners Capital Management Llp 1.34 -74.15
2020-02-12 13G/A Vanguard Group Inc 7.46 1.35
2020-02-10 13G/A BlackRock Inc. 6.30 -3.07
2019-02-12 13G/A Wellington Management Group Llp 7.39 15.98
2019-01-22 13G/A GIC Private Ltd 4.59 -9.18
2018-02-08 13G/A Goldman Sachs Group Inc 0.70 -89.64
2017-02-06 13G/A Price T Rowe Associates Inc /md/ 2.80 -58.06
2016-02-12 13G/A Fmr Llc 4.17
2015-03-23 13D/A Pershing Square Capital Management, L.P. 0.00
2015-02-13 13G/A Capital Research Global Investors 0.00
2014-11-20 13D/A Valeant Pharmaceuticals International, Inc. 0.00
2013-02-13 13G/A Growth Fund Of America 4.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-05-07 10-Q Quarterly Report – 10-Q
2020-05-07 10-Q Quarterly Report – 10-Q
2020-04-29 10-K/A Annual Report – 10-K/A
2020-04-29 10-K/A Annual Report – 10-K/A

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ACB – Aurora Cannabis Inc.
ADCT – Adc Telecommunications Inc ALR – Alere Inc.
AMRX – Amneal Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io